1910 Genetics is the only biotechnology company advancing small and large molecule drug discovery with a multimodal AI platform powered by laboratory automation. We integrate AI with three proprietary data streams – computational data, wet lab proxy biological data, and wet lab ground truth biological data – to deliver novel drug candidates and software solutions to leading pharma and tech partners, and advance our internal pipeline for neurological, autoimmune diseases, and cancer.
We are backed by leading investors including M12 - Microsoft's Venture Fund, Playground Global, Sam Altman, Y Combinator, FoundersX Ventures, Scientia Ventures, and many others.
Company Details
- Employees
- 32
- Founded
- 2018
- Address
- 451 D Street,
- pa****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- 1910genetics.com
- HQ
- Boston, MA
1910 Genetics Questions
1910 Genetics's website is 1910genetics.com
1910 Genetics's LinkedIn profile is https://www.linkedin.com/company/1910genetics
1910 Genetics has
32 employees.
View email and phone details for 32
employees at 1910 Genetics.
1910 Genetics's industry is
Biotechnology Research
1910 Genetics's top competitors are
Incendia Therapeutics,
Qld Biotherapeutics Inc,
Nona Biosciences,
Portal,
Kytopen,
Scismic,
Vivtex,
Marengo Therapeutics,
Manifold Bio,
Pledge Therapeutics.
1910 Genetics's support email address is partnering@1910genetics.com
1910 Genetics's categories are Biotechnology Research
1910 Genetics's founding year is 2018
